Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy
Clinical trial NCT03793608 · COMPLETED
Trial details
- NCT number
- NCT03793608
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-12
- Primary completion
- 2021-02-19
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.